Concepedia

Role of TNFRSF1B polymorphisms in the response of Crohn’s disease patients to infliximab

Luz María Medrano, Carlos Taxonera, Ana Márquez, Manuel Barreiro‐de Acosta, María Gómez–García, Cristina González-Artacho, J.L. Pérez-Calle, Fernando Bermejo, Antonio López–Sanromán, María Dolores Martin‐Arranz,

Human Immunology · 2013 · 59 citations · 14 references

Open access

Concepts

InflammationChronic Inflammatory DiseasesImmunologyGastroenterologyPathologyChronic InflammationInflammatory MarkerImmune-related Gene PolymorphismImmune-mediated Inflammatory DiseasesMedicineInflammatory DiseaseTnfrsf1b Polymorphisms

References

14

A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY

Richard F. Harvey, J.M. Bradshaw · The Lancet · 1980 · 2.9K citations

Inflammation, Functional Gastrointestinal Disorder, Gastroenterology +4

Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

Bruce E. Sands, Frank Anderson, Çharles N. Bernstein et al. · New England Journal of Medicine · 2004 · 2.2K citations · Full text

Classification of Inflammatory Bowel Disease

J E Lennard‐Jones · Scandinavian Journal of Gastroenterology · 1989 · 2K citations

Inflammation, Rheumatology, Functional Gastrointestinal Disorder +12

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease

Paul Rutgeerts, Brian G. Feagan, Gary R. Lichtenstein et al. · Gastroenterology · 2004 · 947 citations

Inflammation, Episodic Treatment Strategies, Anti-inflammatory +4

Individualised therapy is more cost-effective than dose intensification in patients with Crohn’s disease who lose response to anti-TNF treatment: a randomised, controlled trial

Casper Steenholdt, Jørn Brynskov, Ole Østergaard Thomsen et al. · Gut · 2013 · 451 citations